Patients with high IFN-gamma scores and high tumor mutational burden (TMB) had 100% complete pathological response, while patients with low IFN-gamma scores had 88% and 39% complete pathological response, depending on high or low TMB. The gene discussed is IFNG; the disease is neoplasm.